```html

Jaundice During Pregnancy

What is Jaundice (Pregnancy)?

Jaundice is a yellowish discoloration of the skin, sclera (the whites of the eyes), and sometimes mucous membranes caused by elevated levels of bilirubin in the blood. Bilirubin is a by‑product of normal red‑blood‑cell breakdown. During pregnancy, the body undergoes many physiological changes that can affect liver function and bilirubin metabolism, making jaundice a concerning sign that warrants careful evaluation.

While occasional mild elevations of bilirubin are common in early pregnancy, persistent or severe jaundice may signal an underlying liver or hematologic disorder that could affect both mother and baby. Understanding the reasons why jaundice appears during pregnancy helps women and clinicians act quickly to protect health.

Common Causes

In pregnant women, jaundice can stem from a spectrum of conditions—some specific to pregnancy, others unrelated but triggered by the physiological stress of gestation. The most frequent causes include:

• Intrahepatic Cholestasis of Pregnancy (ICP) – A pregnancy‑specific liver disorder that interferes with bile flow, leading to bilirubin buildup. Occurs most often in the third trimester.
• Acute fatty liver of pregnancy (AFLP) – A rare but serious condition that typically presents in the third trimester, causing liver dysfunction and jaundice.
• Pre‑eclampsia/HELLP syndrome – Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) can cause hemolysis and liver injury, resulting in jaundice.
• Viral hepatitis (A, B, C, or E) – Infection of the liver can flare during pregnancy, especially hepatitis E, which is more severe in pregnant women.
• Gallstone disease (biliary colic or cholecystitis) – Obstruction of the bile ducts by stones can impede bilirubin excretion.
• Hemolytic anemia – Conditions such as autoimmune hemolytic anemia or hereditary spherocytosis increase red‑cell breakdown, raising bilirubin.
• Medication‑induced liver injury – Some prescription or over‑the‑counter drugs (e.g., certain antibiotics, antiepileptics) are hepatotoxic.
• Pregnancy‑related hyperemesis gravidarum – Severe, prolonged vomiting can cause dehydration and a mild hepatic dysfunction manifesting as jaundice.
• Maternal metabolic disorders – Wilson’s disease (copper accumulation) or α‑1 antitrypsin deficiency may become evident during pregnancy.
• Sepsis or systemic infection – Severe infections can cause cholestasis and jaundice as part of a multi‑organ response.

Associated Symptoms

Jaundice rarely appears in isolation. Other clinical clues often point to the underlying cause:

• Itching (pruritus), especially on the palms and soles – classic for ICP.
• Right‑upper‑quadrant abdominal pain or tenderness – suggests gallstones or hepatitis.
• Nausea, vomiting, and loss of appetite – common with AFP, HELLP, or hyperemesis.
• Dark urine and pale stools – indicate impaired bilirubin excretion.
• Fever, chills, or malaise – may signal infection or sepsis.
• Bleeding tendencies, bruising, or petechiae – point toward HELLP or severe hemolysis.
• Swelling of the legs or abdomen (edema) – can accompany pre‑eclampsia.
• Fatigue or generalized weakness – a nonspecific but frequent complaint.

When to See a Doctor

Because jaundice can herald serious maternal or fetal complications, prompt medical attention is essential. Seek care if you notice:

• Any yellowing of the skin or eyes, however mild.
• Intense itching without an obvious rash.
• Upper‑abdominal pain, especially if it radiates to the back.
• Dark urine, pale stools, or a sudden change in stool color.
• Fever >38°C (100.4°F), chills, or feeling markedly ill.
• Rapid swelling of hands, feet, or face.
• Bleeding gums, easy bruising, or unexplained petechiae.
• Decreased fetal movement after 28 weeks gestation.

Even if symptoms seem mild, contacting your obstetric provider early can prevent progression to more severe disease.

Diagnosis

Diagnosing jaundice in pregnancy involves a stepwise approach that combines clinical assessment, laboratory testing, and imaging.

1. Detailed History & Physical Exam

• Onset, duration, and progression of yellow discoloration.
• Associated symptoms (pruritus, pain, vomiting, fever).
• Medication and supplement use, including herbal products.
• Personal or family history of liver disease, gallstones, or hemolytic disorders.
• Blood pressure, fundal height, and fetal heart rate assessment.

2. Laboratory Studies

Test	What it Evaluates
Serum total and direct bilirubin	Quantifies bilirubin level and distinguishes conjugated vs. unconjugated.
Liver function panel (ALT, AST, ALP, GGT)	Detects hepatocellular injury or cholestasis.
Complete blood count (CBC) with smear	Looks for hemolysis, anemia, thrombocytopenia.
Coagulation profile (PT/INR, aPTT)	Assesses synthetic liver function.
Serologic tests for hepatitis A, B, C, E	Identify viral hepatitis.
Serum bile acids	Key test for intrahepatic cholestasis of pregnancy (≥10 µmol/L is diagnostic).
Urinalysis	Detects bilirubin, hematuria, infection.

3. Imaging

• Abdominal ultrasound – First‑line to evaluate gallbladder stones, biliary duct dilation, and hepatic texture.
• Magnetic resonance cholangiopancreatography (MRCP) – Non‑contrast technique useful if ultrasound is inconclusive.
• In rare cases, CT scan or MRI may be ordered, balancing fetal radiation exposure.

4. Specialized Tests (if indicated)

• Genetic testing for Wilson’s disease (ceruloplasmin, 24‑hour urinary copper).
• Autoimmune panel (ANA, anti‑smooth muscle antibodies) for autoimmune hepatitis.
• Liver biopsy – reserved for ambiguous cases where diagnosis would alter management.

Treatment Options

Treatment is tailored to the identified cause, gestational age, and severity of maternal/fetal compromise.

1. Intrahepatic Cholestasis of Pregnancy (ICP)

• Ursodeoxycholic acid (UDCA) – 13–15 mg/kg/day in divided doses; improves bile flow, reduces itching, and lowers serum bile acids.<sup>1</sup>
• Topical antihistamines or cholestyramine for symptom control (use with caution).
• Serial fetal monitoring: non‑stress tests twice weekly after 32 weeks.
• Delivery planning: many clinicians aim for delivery at 36–37 weeks to reduce stillbirth risk.

2. Acute Fatty Liver of Pregnancy (AFLP)

• Immediate hospitalization in a high‑dependency unit.
• Supportive care: intravenous fluids, correction of hypoglycemia, and electrolyte balance.
• Coagulopathy management with fresh frozen plasma or vitamin K.
• Prompt delivery (usually by induction or Caesarean) is definitive; maternal liver function typically recovers within days.

3. HELLP Syndrome

• Stabilization with antihypertensives, magnesium sulfate for seizure prophylaxis, and corticosteroids if <34 weeks to improve fetal lung maturity.
• Urgent delivery—often after maternal stabilization—is the cornerstone of therapy.

4. Viral Hepatitis

• Supportive care: rest, adequate nutrition, and avoidance of hepatotoxic substances.
• For hepatitis B, antiviral therapy (e.g., tenofovir) may be indicated if viral load is high.
• Hepatitis E in pregnancy has a high mortality; close monitoring and early delivery may be considered.

5. Gallstone‑Related Disease

• Acute cholecystitis: IV antibiotics and early cholecystectomy (laparoscopic) if feasible.
• Biliary colic without infection: conservative management with diet modification; elective surgery postpartum if needed.

6. Hemolytic Disorders

• Autoimmune hemolytic anemia: corticosteroids or IVIG.
• Hereditary spherocytosis or other genetic hemolysis: folic acid supplementation and, if severe, transfusion.

7. General Supportive Measures

• Hydration: oral or IV fluids to maintain urine output.
• Nutrition: high‑protein, low‑fat diet; avoid alcohol and acetaminophen beyond recommended doses.
• Itch relief: cool compresses, oatmeal‑containing soaps, and, if needed, short‑course antihistamines (e.g., diphenhydramine).

Prevention Tips

While some causes (genetic, viral) cannot be fully prevented, several strategies can reduce the risk of jaundice or its complications during pregnancy:

• Pre‑conception screening for hepatitis B and C; vaccinate against hepatitis A and B if not immune.
• Maintain a healthy weight and balanced diet to lower gallstone risk.
• Stay well‑hydrated and avoid prolonged fasting, especially in the second and third trimesters.
• Limit exposure to known hepatotoxins – certain herbal supplements (e.g., kava, comfrey) and over‑the‑counter medications (e.g., high‑dose acetaminophen).
• Attend all prenatal visits; routine liver function tests are often part of prenatal labs in high‑risk pregnancies.
• Promptly treat any infections** (UTI, gastroenteritis) to prevent secondary liver involvement.
• If you have a known liver condition (e.g., Wilson’s disease), work closely with a hepatologist and an obstetrician experienced in high‑risk pregnancies.

Emergency Warning Signs

Key Takeaways

• Jaundice in pregnancy signals an abnormal rise in bilirubin and can stem from pregnancy‑specific liver disorders or unrelated hepatic, biliary, or hematologic diseases.
• Prompt recognition, thorough evaluation, and targeted treatment are essential to safeguard both mother and baby.
• Regular prenatal care, safe medication use, and early reporting of itching or yellow discoloration dramatically improve outcomes.

---

References:

1. American College of Obstetricians and Gynecologists. “Intrahepatic Cholestasis of Pregnancy.” ACOG Practice Bulletin No. 212, 2020.
2. Mayo Clinic. “Acute fatty liver of pregnancy.” Updated 2023.
3. Cleveland Clinic. “HELLP Syndrome.” 2022.
4. World Health Organization. “Guidelines for the prevention and treatment of hepatitis E.” 2021.
5. National Institutes of Health. “Ursodeoxycholic Acid for Intrahepatic Cholestasis of Pregnancy.” ClinicalTrials.gov Identifier NCT01895873.
6. Centers for Disease Control and Prevention. “Hepatitis B FAQs for Health Professionals.” Accessed March 2024.

```